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Activation of resting Ly-2’ precursor T cells to cytotoxic T 
lymphocytes  (CTL)’  requires  stimulation  by  antigen  or  mitogen 
in combination with soluble  mediators  (1 -3). One of  these  anti- 
gen-nonspecific  mediators is interleukin  2  (IL 2). IL 2 is released 
by activated Ly-l+ helper  T  cells  and  was  distinguished to provide 
the  proliferative  signal  (4, 5). It was  only  recently  discovered that 
IL 2 is not the only helper factor required for the cytotoxic 
response  (4-12).  In  this  report,  we  provide  evidence  that  three 
different, previously described activities (1 2) are sequentially 
required in distinct  phases  of  the cytotoxic response.  Absorption 
of  Con  A-induced  spleen  cell  supernatants  (Con  A-Lk)  on IL 2- 
dependent  T  cell  line  cells  removes  the IL 2  activity, but a  factor 
remains that is required  through  the  first  48  hr  of  culture  and is 
referred to as T  cell  cytotoxicity-inducing  factor 1 (TCF1) in this 
report.  Another  factor is only  required in the  last  48 hr of culture 
and is called  TCF2. Its activity  can be destroyed in Con  A-Lk  by 
dialysis at pH 2, a  treatment that leaves IL 2 titers unchanged 
(10-12). It is different  from TCFl because it is also present in 
phorbol  myristic  acetate-activated  EL-4  thymoma  cell  superna- 
tants  that  lack  TCF1. IL 2 is the  third  factor  and is required  at 
least  in  the  early  phase. 
MATERIALS AND METHODS 
Mice. C3HflIF and  DBA/2J  were  purchased  from  Bomholtgard, Ry, Den- 
mark  and  were  used  at  6 to 10 wk  of  age. 
Culture  medium.  The  culture  medium  used  was RPMll640 (GIBCO,  Grand 
Island,  NY;  powdered  media) with Lglutamine (2 x 1 0-3 M)  and  supplemented 
anol(4 x M)  and  gentamicin (50 pg/ml). 
with  10%  heat-inactivated  fetal  calf  serum,  HEPES’  (0.02  M),  2-mercaptoeth- 
Lymphokine preparations. ConA-Lk supernatants were prepared b con- 
ventional  methods.  Splenic  single  cell  suspensions  were  adjusted to 10 cells/ 
ml in culture medium and were incubated for 24 hr with 5 pg Con A/ml 
(Pharrnacia, Uppsala, Sweden) in moist air containing 5% C02. To cellfree 
supernatants, a-methyl-o-mannoside (Sigma Chemical. St. Louis, MO) was 
added to a  final  concentration  of 10 mM.  All  preparations  were  stored  at 4OC. 
cultured  with 3 x 1 Os glutaraldehyde-fixed  TNP-haptenated  syngeneic  spleen 
T cell cyfotoxicity  assay.  Nylon  wool-purified  thymocytes (105) were co- 
cells  as  stimulators.  Varying  amounts  of  lymphokine  preparations  were  added 
cytotoxic activity  was  measured  on  day 5 in a  3-hr  %r-release test with the 
on day 0 and/or  day  3 so that  the total volume  per  well  was  0.16  ml.  The 
use  of 5 x lo3 prelabeled  TNP-modified  tumor  targets  (L929,  mouse  fibro- 
sarcoma). 
Assay for IL 2 activity.  The  amount  of IL 2 in supernatants  was  measured 
by  their  ability to support  the growth of  the IL Pdependent cell  line  W-2 (1 0- 
0.5 pCi  of  methyl-[3H]thymidine  (specific  activity 50 Ci/mol,  Amersham  Inter- 
12).  Thymidine  incorporation  after  a  20-hr  incubation  and  a  4-hr  pulse  with 
laboratory  units  as  described  by  Farrar  et  a/.  (1 3).
national Ltd, Amersham, UK) was determined. Results are expressed in 
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’ Abbreviations  used:  Con  A-Lk.  concanavalin  A-lymphokine;  IL 2, interleukin 2; 
inducing  factors 1 and 2; HEPES, N-2-hydroxyethylpiperazine-N’-Z-ethanesulfrnic 
IL 1, interleukin 1; CTL.  cytotoxic  T  lymphocyte; TCFl and 2, T  cell  cytotoxicity- 
acid. 
described  by  Hilfiker et al. (14). EL4 thymoma cells  (generously supplied  by 
Preparafion of partially purified IL 2. An IL 2 preparation  was prepared  as 
J.  J.  Farrar,  NIDR,  NIH,  Bethesda,  MD)  were  suspended  at  10E/ml in RPMl 
1640  containing  no  serum  or 0.5% heat-inactivated horse serum.  Ten  nano- 
grams  per  milliliter  of phorbol myristic  acetate  were  added  and  the  cells  were 
incubated  for 48 hr.  The  cellfree  supernatant  was  concentrated on an  Amicon 
PM 10 membrane. Proteins were then precipitated with ammonium sulfate 
(80%  saturation). A small  amount  of  FCS  was  added to preparations  made 
without  serum to prevent loss of  activity  during  purification.  The  precipitate 
equilibrated  with 0.8 M  ammonium sulfate in 0.01  M phosphate buffer, pH  7, 
was washed once and  dissolved in water.  The dissolved material was 
and  was  applied to a  phenyl-Sepharose  column  (Pharmacia).  The  column  was 
then  washed  with  2  vol  of 0.64 M ammonium  suifate + 10% ethanediol.  The 
IL P-containing peak was finally eluted with 40% ethanediol in 0.16 M 
ammonium  sulfate.  The IL 2  fractions  were  concentrated  on an  Amicon  PM 
10 membrane  and  were  equilibrated  with  column  buffer (0.05 M  Tris-hydrox- 
ymethylacetate, 0.1 M sodium chloride, pH 7.2, containing 0.05% polyeth- 
yleneglycol 6000). The material was then applied to a Sephadex G-100 
column  and  the  activity  was  eluted  with  an  apparent  m.w.  of  approximately 
32,000.  The  peak  fractions  were  pooled  and  dialyzed  against  culture  medium 
after  adding  FCS to a  final  concentration  of  10%. 
Absorption of f L  2. Con A-induced  supernatants  were  depleted  of IL 2  by 
absorption with an IL 2  receptor-bearing  T  cell  line.  One  milliliter of ConA- 
incubated  for 48 hr. The  cells  were  then  centrifuged,  and  the  supernatant 
induced  supernatant  was  mixed  with  approximately lo5 W-2 cells and  was 
was  dialyzed  against  culture  medium  and  then  incubated for 48 hr  with lo5 
W-2  cells/ml.  The  supernatant  was  again  dialyzed  against  culture  medium. 
These  supernatants  were  devoid  of  any  trace  of IL 2  activity. 
50 mM  glycine  buffer,  pH  2,  and  were  readjusted o pH  7  by  dialysis in culture 
Dialysis  at pH 2. Con  A-induced  supernatants  were  dialyzed  overnight  in 
medium. 
RESULTS AND DISCUSSION 
Responder  cells (1 05) were co-cultured with TNP-haptenated 
syngeneic stimulator cells (3 x lo5) that had been fixed with 
glutaraldehyde to prevent proliferation as well as metabolism. 
Cytotoxicity was  determined  after 5 days  of  culture  against  Con 
A-induced blasts or tumor targets in a 3-hr 5’Cr-release test. 
Development  of  CTL activity was  detected  under  these  stringent 
conditions only after  the  addition  of  helper  factors.  Substantial 
cytotoxicity was  obtained  only  when  a  large  dose  of  Con  A-Lk 
was  added  on  day 0 or  when two doses  of  Con  A-Lk  were  added 
to the cultures  on day 0 and  day  3,  which  as  single  doses  at  day 
0 or  day 3 were  suboptimal  (Table I, lines  1-4).  This  synergistic 
response  was  also  obtained  when  the  Con  A-Lk  added  on  day 
3 was replaced by a semipurified IL 2 preparation from EL-4 
supernatants  (line 5); the  response  was  lost  when it was  replaced 
by the pH  2-treated  Con  A-Lk,  which  had  the  same IL 2  titer (line 
6). This indicated that the Con A-Lk contained a helper factor 
that was different from IL 2, sensitive to pH 2  treatment, and 
present  in  the IL 2  preparation  from  EL-4.  This  factor  was  called 
TCF2 in this study. Good CTL responses were measured in 
cultures  that  contained  only  pH  2-treated  Con  A-Lk in the  begin- 
ning  and  received  Con  A-Lk  or EL4derived IL 2  preparations 
on  day 3 (lines  10  and  11).  This  showed  that  the  pH  2-sensitive 
TCF2 activity was not required in the  early  phase of Culture. 
On the  other  hand, it was not sufficient to furnish  the  cultures 
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TABLE I 
Effec t  of sequential addition of various  lymphokine  preparations on the induction 
of CTL  responses' 
Addition of Lymphokines 
Specific %r 
Percent 
Day 0 Day 3 Release 
1 
2 
3 
4 
5 
6 
7 
8 
9 
11 
10 
12 
13 
14 
15 
- 
- 
Con  A-Lk 
Con A-LK 
Con  A-Lk 
Con  A-Lk 
pH 2-treated  Con  A-Lk 
pH  2-treated  Con  A-Lk 
pH 2-treated  Con  A-LK 
pH 2-treated Con A-Lk 
- 
EL-4-IL  2  preparation 
EL-4-IL  2  preparation 
EL-4-IL  2  oreoaration 
- 
16 EL-4-IL  2  preparation 
The  cultures  were  provided on day 0 with 0.04 ml and/or  day 3 with 0.04 ml 
(Con  A-Lk).  This  preparation had an IL 2 titer of 132 U/rnl; b) same  as  a but dialyzed 
of different lymphokine preparations: a) Con A-induced spleen c e l l  supernatant 
overnight in pH 2  buffer  (pH 2-treated Con  A-Lk).  This  preparation had the  same 
IL 2 titer as a; c) semipurified IL 2 preparation from phorbol myristic acetate- 
4-IL  2  preparation).  (incorporated  cpm = 2200;  background  8%; SEM of specific 
induced  EL-4  thymoma cell supematant  (13,  14) with an IL 2 titer of 400 U/ml (EL- 
cytotoxicity ~2.3%). 
~ ~~ 
Con  A-Lk 
Con  A-Lk 
EL-4-IL  2  preparation 
pH  2-treated Con A-Lk 
pH 2-treated Con A-Lk 
Con  A-Lk 
pH  2-treated  Con  A-LK 
EL-4-IL  2 preparatiin 
EL-4-IL  2  preparation 
Con  A-Lk 
EL-4-IL  2  preparation 
DH 2-treated Con A-Lk 
- 
- 
- 
- 
0.0 
0.0 
6.3 
22.0 
28.5 
0.0 
0.0 
2.0 
23.5 
21 .a 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
Time ( h )  Specific %-release 
0 24 48 72 
+ Test (Yo) - 25.0 
L 3.5 
0 - 0 
P 13.1 
1 0.5 
0 I 
L-1 IL2+TCF2 - T C F l  
figure 1. Influence  of  time of addition  of two complementary  lymphokine prep 
arations  on  the  induction of CTL  responses.  The  following  lymphokine  preparations 
were used: a) IL 2 + TCF2: semipurified IL 2  preparation from phwbol myristic 
acetate-induced EL4 thymoma supernatant (13, 14); b) TCF1: Con A-induced 
spleen cel supernatant depleted of IL 2 and TCF2 by two absorptions on IL 2 
receptor-bearing  T  cells (W2) (incorporated  cpm = 1000;  background  13%; SEM 
of specific  Cytotoxicity c 2.3%). 
with IL 2 and TCF2 by using the IL 2 preparations from EL4 
supernatants in the early phase. In this case, a cytotoxic re- 
sponse was not induced either with a second dose of EL-4- 
derived IL 2 preparation or with the late addition of Con A-Lk 
(lines 13-15). The ineffectiveness of this combination was not 
due to the  lack  of IL 2  in  the  early  phase  because  the  EL-4-IL  2 
preparation  had  an IL 2  titer  of 400 U/ml.  Thus, in  contrast to 
the IL 2  preparation  from  EL-4,  the  Con  A-Lk  as  well  as  the  pH 
2-treated Con A-Lk contained another helper factor that was 
required in the early phase of culture. This factor was called 
TCFl . 
It was  shown  previously that  absorption  of  Con  A-Lk  on IL 2- 
dependent  T  cell  line  cells  yields  a  preparation that  contains  a 
factor different from IL 2 that is required for the induction of 
cytotoxicity (4, 5, 10). Reconstitution experiments have also 
shown that it synergized with EL-4derived IL 2 preparations 
(1  0-1 2; Fig. 1). These results  indicated  the  absorbed  preparation 
contained  TCF1.  Similar  experiments  established  that not only 
IL 2 was  removed  by this  absorption  procedure but also  TCF2 
(1 0-1 2). 
The three different lymphokine preparations lacking one or 
two of  the  required  helper  activities  were  utilized  in  kinetic  studies 
to determine  more  precisely  the  time  points  of  requirement  for 
TCFI , It 2,  and  TCF2.  Figure 1 shows  that TCFl (the  absorbed 
Con  A-Lk)  had to be available no later  than  on  day 0 together 
with IL 2. Because  the  absorbed  preparation  was  devoid  of IL2, 
we found as expected that the delayed addition of the EL-4- 
derived IL 2  preparation  reduced  the  cytotoxic  response.  Pre- 
culture  in TCFl and  addition  of IL 2  and  TCF2 1 day  later  induced 
a  relatively  weak  but  still  significant  CTL  response  on  day 5. 
Pulse  experiments  with TCFl are  shown  in  Figure 2. A  24-hr 
pulse with TCFl at any  time  proved to be  insufficient,  even  when 
given  together  with IL 2  at  the  time  of  culture  initiation.  Substan- 
tial  cytotoxic  activity  was  obtained,  however,  when TCFl was 
present for the first 48 hr. No further increase was observed 
when  the  same  amount  of TCFl was left  in  the  culture  for  more 
than  48  hr.  The  combination  of  the EL4derived IL 2  preparations 
plus TCFI for 48 hr  was not  sufficient  for  the  induction  of  the 
GTL  response. 
Similar  kinetic  experiments  were  performed to determine  the 
exact  time  span  for  the  requirement for TCFP. It was  found  that 
the  addition  of  TCF2  any  time  between  day 0 and  day 3 gave 
essentially  the  same  CTL  response,  whereas  synergism  was lost 
0 24 48 72 
T ime ( h )  Specific 5kr-re1ease . Test ( O/O 
P 25.0 
I 0 
0 
 0 
0 
22.3 
I 25.7 - 0 
0 IL2 +TCF2 0 TCFl 
For details see  legend to Figure 1 (incorporated cpm = 1600 background 17%; 
figure 2. lnfluence of pulsing with TCFl on  the  induction of CTL responses. 
SEM Of specific  CytOtOXidty 5 2.3%). 
T ime  ( d )  Speclflc ''~r-re~ease 
0 1 2 3 4 5 T e s t  
( O/O ' 
6.0  0 - 0 
30.0 
17.7 
8.3 
0.6 
O I L 2  +TCF1 O l L 2 + T C F 2  
Figure 3. Influence of time  of  addition of  two complementary  lymphokine prep 
arations on the induction of CTL  responses.  The  following  lymphokine  preparations 
2  buffer.  The IL 2 titer was  130 U/ml; b) IL 2 + TCF2:  semipurified IL 2  preparation 
were  used.  a) IL 2 + TCFl : Con  A-induced  spleen cel supernatant  dialyzed  in pH 
titer:  400  U/ml).  Lymphokine  preparations  were  either  added on day  3 or superna- 
from  phcfbol  myristic acetateinduced EL4 thymoma  supernatant  (13,  14)  (IL 2 
tant  was  taken off the  cultures  and  replaced  by  another  lymphokine  (incorporated 
cpm = 1300;  background  12%;  SEM of specific  cytotoxicity I 2.3%). For other 
details see legend to Figure 1. 
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when  TCF2  was  provided  on  day 4 or  later  (data  not  shown). 
Figure 3 confirms that the addition of the EL-4-derived IL 2 
preparation (IL 2  and  TCF2) on day 3 to cultures  containing  pH 
2-treated Con A-Lk (TCFl and IL 2) produced good CTL re- 
sponses. Substantial  responses  were  obtained  when  the  pH  2- 
treated  Con  A-Lk  was  present  from  day 0 through  day 5 or  day 
0 through  day 3. The  difference in cytotoxic  activity  in  these two 
situations  may be explained  by  the  different  IL  2  concentration 
in the  late  phase.  The  cytotoxic  activity  was  markedly  reduced, 
however,  when  TCF2  was  only  present  from  day 3 through  day 
4, indicating  that  the  TCF2  activity  was  required  until  the  end  of 
the  culture.  The  remaining  weak  cytotoxicity  could be ue to the 
incomplete  inactivation  of  TCF2  by  the  pH  2  treatment  (1  2). 
Taken  together,  our  experiments  demonstrate  the  requirement 
for  three  functionally  and  biochemically  different  helper  activities 
in  the  cytotoxic  response. II 2  is  required  at  least  in  the  early 
phase  of  the  culture  period. TCFl is required  at  the  initiation  of 
the  culture  for  a  minimum  of 48 hr.  This  factor  is  indistinguishable 
from the differentiation factor described previously (4, 5). It is 
possible  that it acts  on  the  CTL  precursor  before IL 2  receptors 
are  expressed.  Preliminary  experiments in which  semipurified IL 
1 preparations from Con A-induced spleen cells were used 
indicated  that TCFl cannot be replaced  by IL 1.  TCF2,  on  the 
other  hand, is only  required in the  final  phase  and  not in the early 
phase  of  CTL  activation.  The  requirement  for  a  late-acting  soluble 
helper  factor  different  from IL 2  has  been  described  in  a  previous 
report (6). It was  shown  that  this  late  helper  effect  was  activated 
by  stimulation  with  a  foreign I region  determinant.  The  biochem- 
ical  characterization  of TCFl and  TCF2,  their  cellular  origin,  and 
their  mechanism  of  action  are  currently  under  investigation. 
Recent  publications  revealed two distinct phases  of  the cyto- 
toxic  response,  Le.,  an  early antigendriven phase  and  a  second 
phase  that  was  dependent  on IL 2antaining lymphokines  (15- 
17). The experiments in this  paper  showed  that  the  cytotoxic 
response is even more complex and requires the sequential 
action  of  at  least  three  different  helper  activities  that  are  provided 
by soluble mediators. Mixing experiments excluded inhibitor 
action  (12). So far,  TCF2  and IL 2  co-purified,  and  there  is  the 
possibility  that  the two activities  reside  on  the  same  molecule. 
The  early  helper  factor TCFl is  clearly  separable  from IL 2. It is 
absent  from  the EL4 supernatant  and is not  absorbed  by  the IL 
2dependent cel line.  The  sequential  action  of  several  factors in
CTL  responses  was  strikingly  similar to the  conditions  of B cell 
activation and functional differentiation (Reference 18; K. Nak- 
anishi,  personal  communication).  In  addition to a B cell  growth 
factor, two more soluble differentiation factors were required, 
one  of  which  acts  at  an  early  stage  of  activation  and  the  second 
one  at  a  later  stage. It remains to be tested  whether  these B cell 
differentiation  factors  are  related  to  the  helper  activities  neces- 
sary for  the  induction  of  T  cell-mediated  cytotoxicity. 
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